The Liposcale® Test Provides Precise and Accurate Analytical Results.

The Liposcale® test provides much more precise and accurate analytical results than other currently used methods, as it employs the latest 2D Nuclear Magnetic Resonance technology to make a physical measurement of the particles, including the physical size and number of the different subclasses of lipoproteins. This method is an alternative to the current 1D NMR methods. The analytical results offer high reproducibility, validity and precision. It is a robust standardized technique that is easily transferred to clinical practice thanks to its speed.

The Liposcale® Test is an advanced lipoprotein test based on Nuclear Magnetic Resonance (NMR), which directly measures the normal lipid profile, in addition to the particle number and size, the cholesterol and triglyceride composition of the main lipoprotein classes and subclasses (VLDL, LDL, HDL).

download
Sample Report

The Liposcale® Report is Easy to Interpret and Utilize For Patient Education

Liposcale® Software

The Liposcale® medical software algorithm developed by Biosfer Testlab SL is patented and has been granted CE marking. It generates a report that provides a full characterisation of the lipoprotein profile.

The software generates a report, the LIPOSCALE® test, containing the following parameters and data:

The lipoproteins with the greatest atherogenic potential (1), y are medium and small VLDL and small dense LDL particles (2)

  • The basic lipid profile: total cholesterol concentration, LDL-C, HDL-C, triglycerides (TG), remnant cholesterol and non-HDL cholesterol (non-HDL-C).
  • Total number of lipoprotein particles (VLDL, LDL and HDL), classified according to size (large, medium and small), the mean size of VLDL, LDL and HDL particles, and the degree to which they deviate from the percentiles in the reference population.

Liposcale® Report

Structure of the report:

  • The values are given in digital format so that they can be exported or integrated into any other custom report and used for patient assessment and/or monitoring.
  • The test provides information about target values according to the patient’s cardiovascular risk (very high, high, moderate/low).

In different metabolic conditions, including:

  • Atherogenic Dyslipidemia
  • Abdominal Obesity
  • Insulin Resistance
  • Metabolic Syndrome (MS)
  • Type 2 Diabetes Mellitus
  • Chronic Conditions (kidney disease or chronic inflammation)

An increased triglyceride content is detected in the lipoproteins. This excess is metabolized, leading to a larger number of smaller LDL particles with greater atherogenic potential.

This leads to discordance between particle number and cholesterol concentration.

  • The lipoproteins with the greatest atherogenic potential (1), y are medium and small VLDL and small dense LDL particles (2)
  • The number of LDL particles (LDL-P), and particularly small dense LDL particles (sdLDL), provides a better prediction of CVD than the standard lipid profile.(3)
  • Plasma LDL-C may not reflect the real concentration of LDL particles. Therefore, in patients with discordant LDL-C and LDL-P values, LDL-P it offers a better prediction of cardiovascular risk.(4)
  1. Amor AJ, Catalan M, Pérez A, et al. Nuclear magnetic resonance lipoprotein abnormalities in newly-diagnosed type 2 diabetes and their association with preclinical carotid atherosclerosis. Atherosclerosis. 2016;247:161–9.
  2. Cromwell WC, Otvos JD. Low-density lipoprotein particle number and risk for cardiovascular disease. Current Atherosclerosis Reports. 2004;6:381–7.
  3. Mallol R, Amigó N, Rodríguez MA, et al. Liposcale: a novel advanced lipoprotein test based on 2D diffusion-ordered 1H NMR spectroscopy. Journal of Lipid Research. 2015;56:737–46.
  4. Otvos JD, Mora S, Shalaurova I, et al. Clinical Implications of Discordance Between LDL Cholesterol and LDL Particle Number. Journal of Clinical Lipidology. 2011;5:105–13.

Advancing Non-Invasive Diagnostics.

info
Contact Us

300E Sonterra Blvd., Suite 1110
San Antonio, Texas 78258

check_circle
Order OWLiver® Test

OWLiver® is a non-invasive blood test to assess MASLD. It analyzes a panel of biomarkers through metabolomics methodology.